Aurinia Pharmaceuticals Inc. (FRA:IKAP)
12.91
+0.32 (2.58%)
Last updated: Dec 5, 2025, 8:04 AM CET
Aurinia Pharmaceuticals Market Cap
Aurinia Pharmaceuticals has a market cap or net worth of €1.73 billion as of December 5, 2025. Its market cap has increased by 57.45% in one year.
Market Cap
1.73B
Enterprise Value
1.50B
Revenue
226.55M
Ranking
n/a
PE Ratio
26.09
Stock Price
€12.91
Market Cap Chart
Since August 27, 2012, Aurinia Pharmaceuticals's market cap has increased from 5.70M to 1.73B, an increase of 30,281.06%. That is a compound annual growth rate of 53.78%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 242.06B |
| Siemens Aktiengesellschaft | 175.97B |
| Allianz SE | 141.37B |
| Deutsche Telekom AG | 131.00B |
| Siemens Energy AG | 98.87B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 69.10B |
| Rheinmetall AG | 68.36B |
| Deutsche Bank Aktiengesellschaft | 59.35B |